SPERO THERAPEUTICS INC (SPRO:NASDAQ)
$2.93 0.07 (2.4476%)
Analysed SPERO THERAPEUTICS INC (SPRO:NASDAQ) News Sources
Is Spero Therapeutics (NASDAQ:SPRO) In A Good Position To Deliver On Growth Plans?
15-12-2025
yahoo.com
Spero Announces NDA Resubmission of Tebipenem HBr by GSK to the FDA for the Treatment of Complicated Urinary Tract Infections, Including Pyelonephritis
19-12-2025
yahoo.com
3 Promising Penny Stocks With Market Caps Up To $300M
07-01-2026
yahoo.com
Airgain And 2 Other Promising Penny Stocks
05-02-2026
yahoo.com
Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026
18-03-2026
yahoo.com
Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update
26-03-2026
yahoo.com
Uncovering 3 Penny Stocks With Market Caps Under $700M
08-04-2026
yahoo.com
Inventiva Builds Up Leadership Team Ahead of Potential Commercialization
22-04-2026
yahoo.com
Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update
13-05-2026
yahoo.com
Promising Penny Stocks To Consider In May 2026
15-05-2026
yahoo.com
What is the current price of SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The current price of SPERO THERAPEUTICS INC (SPRO:NASDAQ) is $2.93.
SPERO THERAPEUTICS INC (SPRO:NASDAQ) absolute price change since previous trading day?
The absolute price change of SPERO THERAPEUTICS INC (SPRO:NASDAQ) since the previous trading day is $0.07.
SPERO THERAPEUTICS INC (SPRO:NASDAQ) percentage price change since previous trading day?
The percentage price change of SPERO THERAPEUTICS INC (SPRO:NASDAQ) since the previous trading day is 2.4476%.
What is the most recent average sentiment score for SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The most recent average sentiment score for SPERO THERAPEUTICS INC (SPRO:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for SPERO THERAPEUTICS INC (SPRO:NASDAQ)?
The most recent sentiment for SPERO THERAPEUTICS INC (SPRO:NASDAQ) is .
SEC-8K** Filing Available For SPERO THERAPEUTICS INC (SPRO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.